Lykis Ltd
₹ 42.6
0.40%
22 Nov
- close price
- Market Cap ₹ 82.6 Cr.
- Current Price ₹ 42.6
- High / Low ₹ 82.6 / 39.5
- Stock P/E 34.6
- Book Value ₹ 17.2
- Dividend Yield 0.00 %
- ROCE 7.88 %
- ROE 13.1 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.8%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Tax rate seems low
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.3.63 Cr.
- Promoter holding has decreased over last 3 years: -11.8%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
22 | 129 | 168 | 107 | 107 | 148 | 147 | 84 | 63 | 329 | 454 | 404 | 370 | |
24 | 130 | 166 | 104 | 110 | 149 | 145 | 85 | 71 | 329 | 429 | 395 | 364 | |
Operating Profit | -2 | -1 | 2 | 2 | -3 | -1 | 2 | -1 | -8 | 0 | 25 | 10 | 7 |
OPM % | -9% | -1% | 1% | 2% | -3% | -1% | 2% | -1% | -12% | 0% | 6% | 2% | 2% |
1 | 2 | 1 | 1 | 3 | 3 | -1 | 2 | 1 | 6 | 3 | 3 | 4 | |
Interest | 1 | 1 | 2 | 2 | 3 | 5 | 2 | 3 | 2 | 3 | 7 | 8 | 6 |
Depreciation | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 | 2 |
Profit before tax | -2 | -1 | 0 | 1 | -3 | -4 | -2 | -2 | -9 | 2 | 20 | 4 | 2 |
Tax % | 3% | 55% | 76% | 64% | 4% | -3% | 45% | 0% | -28% | -7% | 19% | -5% | |
-2 | -1 | 0 | 0 | -3 | -4 | -2 | -2 | -7 | 2 | 16 | 4 | 2 | |
EPS in Rs | -0.62 | -1.02 | 0.06 | 0.18 | -1.78 | -1.85 | -1.25 | -0.98 | -3.47 | 1.25 | 8.12 | 2.00 | 1.22 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 22% |
3 Years: | 86% |
TTM: | -16% |
Compounded Profit Growth | |
---|---|
10 Years: | 17% |
5 Years: | 38% |
3 Years: | 37% |
TTM: | -84% |
Stock Price CAGR | |
---|---|
10 Years: | 1% |
5 Years: | 20% |
3 Years: | 11% |
1 Year: | -29% |
Return on Equity | |
---|---|
10 Years: | 3% |
5 Years: | 15% |
3 Years: | 37% |
Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 15 | 19 | 19 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
Reserves | 4 | 5 | 5 | 8 | 3 | -3 | -2 | -4 | -10 | -8 | 8 | 12 | 13 |
3 | 45 | 62 | 52 | 86 | 113 | 43 | 49 | 51 | 113 | 144 | 89 | 83 | |
15 | 12 | 17 | 24 | 10 | 44 | 36 | 10 | 27 | 11 | 13 | 21 | 16 | |
Total Liabilities | 37 | 82 | 102 | 104 | 119 | 174 | 98 | 76 | 88 | 135 | 185 | 141 | 132 |
12 | 12 | 11 | 13 | 13 | 14 | 13 | 15 | 3 | 4 | 5 | 5 | 4 | |
CWIP | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 10 | 5 | 12 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
24 | 59 | 84 | 79 | 105 | 159 | 83 | 59 | 85 | 130 | 179 | 136 | 127 | |
Total Assets | 37 | 82 | 102 | 104 | 119 | 174 | 98 | 76 | 88 | 135 | 185 | 141 | 132 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-11 | -29 | -22 | 15 | -33 | 2 | 36 | 9 | -22 | -64 | -23 | 66 | |
-0 | -11 | 4 | -8 | 9 | 0 | 2 | -0 | 9 | 10 | -0 | -1 | |
14 | 44 | 16 | -6 | 33 | 23 | -68 | -8 | 13 | 58 | 21 | -63 | |
Net Cash Flow | 3 | 5 | -2 | 2 | 10 | 25 | -30 | 1 | 0 | 3 | -3 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 122 | 60 | 96 | 75 | 107 | 74 | 49 | 40 | 114 | 67 | 100 | 87 |
Inventory Days | 64 | 9 | 8 | 20 | 19 | 23 | 14 | 4 | 80 | 17 | 15 | 10 |
Days Payable | 161 | 31 | 32 | 10 | 20 | 18 | 45 | 22 | 56 | 11 | 8 | 12 |
Cash Conversion Cycle | 25 | 38 | 72 | 85 | 105 | 79 | 18 | 22 | 138 | 73 | 106 | 86 |
Working Capital Days | 179 | 110 | 135 | 162 | 263 | 168 | 87 | 112 | 243 | 122 | 129 | 95 |
ROCE % | 1% | 2% | 4% | -0% | 1% | 3% | 1% | -12% | 6% | 18% | 8% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 4 Nov
- Unaudited Financial Result For The Period Ended September 30, 2024 1 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting
1 Nov - Board approved un-audited financial results for Q2 2024.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 22 Oct
-
Board Meeting Intimation for Consideration And Approval Of Un - Audited Financial Result For The Quarter And Half Year Ended September 30, 2024
17 Oct - Board meeting to approve financial results on November 1, 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company offers manufacturing support for private labelling in domestic and 40+ countries